Form 4: Arteris 10% Owner Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold 40,000 shares of common stock for approximately $16.46 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Bayview Legacy, LLC, a 10% owner of Arteris, Inc. (AIP), disposed of 40,000 shares of common stock.
- The transaction occurred on December 4, 2025.
- The shares were sold at a weighted average price of $16.4618 per share, with individual transaction prices ranging from $16.25 to $16.65.
- This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Bayview Legacy, LLC on March 5, 2025.
- Following the transaction, Bayview Legacy, LLC beneficially owns 9,599,071 shares of Arteris, Inc. common stock.
- K. Charles Janac, the manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over these shares and filed a separate Form 4 for the same transaction.
Sentiment
Score: 5
Explanation: The sale of shares by a 10% owner is generally neutral given it was executed under a pre-arranged 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new company developments.
Positives
- The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled and planned liquidity event rather than an immediate reaction to company-specific news.
Negatives
- A reduction in beneficial ownership by a 10% owner, even if pre-planned, can sometimes be perceived by the market as a slight decrease in insider alignment.
Future Outlook
NA
Management Comments
- K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
- K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
Industry Context
This filing is specific to an insider transaction for Arteris, Inc. and does not provide broader industry context or trends.
Related Party Transactions
- Bayview Legacy, LLC, a 10% owner, is controlled by K. Charles Janac, who is also deemed to have beneficial ownership and filed a separate Form 4 for the same transaction, indicating a related party transaction.
Stakeholder Impact
- Shareholders may perceive a slight reduction in insider alignment, though the 10b5-1 plan mitigates concerns about immediate negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 2025-03-05 | Date the 10b5-1 trading plan was adopted by the Reporting Person. |
| 2025-12-04 | Date of the reported transaction (sale of common stock). |
| 2025-12-08 | Date the Form 4 was signed by K. Charles Janac. |
Recommendation
holdThe sale of shares by a 10% owner, while reducing insider ownership, was conducted under a pre-arranged 10b5-1 plan. This suggests a planned liquidity event rather than a reaction to adverse company-specific news. Without additional information on company performance or strategic shifts, this transaction alone does not warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.
Keywords
Arteris Inc., AIP, SEC Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Beneficial Ownership, Bayview Legacy LLC, K. Charles Janac, Equity Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.